Whitehawk Therapeutics WHWK
NASDAQ WHWK
$3.70 -0.06 (-1.60%)
At close: Oct 2, 2026 · 4:00 PM EDT

Whitehawk Therapeutics (WHWK) Cash & Equivalents (2010 - 2026)

Updated

Whitehawk Therapeutics' Cash & Equivalents was $85.23 million in Q2 2026, down 41.2% from $144.94 million a year earlier but up 145.0% from the prior quarter.

Analysis

Whitehawk Therapeutics (WHWK) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at Whitehawk Therapeutics came in at $37.57 million, up 31.0% from FY2024.

  • Cash & Equivalents shows a five-year compound annual growth rate of 53.2% (FY2020 to FY2025).
  • In earlier years, Cash & Equivalents was $28.67 million in FY2024 (-54.4%), $62.89 million in FY2023 (+61.2%), $39.02 million in FY2022 (-73.8%) and $148.99 million in FY2021.
  • Quarterly Cash & Equivalents has moved between $28.67 million (Q4 2024) and $227.57 million (Q1 2025) over five years.
  • Compared with a year earlier, Cash & Equivalents was higher in four of the last eight quarters, with growth averaging 49.3%.
  • The best year-over-year quarter for Cash & Equivalents over five years was Q1 2025 (growth of 323.1%); the worst was Q1 2026 (a decline of 84.7%).
  • Per Business Quant data, WHWK's Cash & Equivalents in the three quarters before Q2 2026 was $34.79 million (Q1 2026), $37.57 million (Q4 2025) and $37.93 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Whitehawk Therapeutics 306.68 Mn 306.68 Mn - 85.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 85.23 Mn
Mar 31, 2026 34.79 Mn
Dec 31, 2025 37.57 Mn
Sep 30, 2025 37.93 Mn
Jun 30, 2025 144.94 Mn
Mar 31, 2025 227.57 Mn
Dec 31, 2024 28.67 Mn
Sep 30, 2024 30.54 Mn
Jun 30, 2024 41.14 Mn
Mar 31, 2024 53.78 Mn
Dec 31, 2023 62.89 Mn
Sep 30, 2023 68.80 Mn
Jun 30, 2023 68.16 Mn
Mar 31, 2023 34.05 Mn
Dec 31, 2022 39.02 Mn
Sep 30, 2022 134.82 Mn
Jun 30, 2022 118.74 Mn
Mar 31, 2022 129.85 Mn
Dec 31, 2021 148.99 Mn
Sep 30, 2021 161.40 Mn
API Access

Whitehawk Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=WHWK&period=max&api_key=YOUR_API_KEY